Background: Stroke is the third most common cause of mortality and one of the leading causes of adult physical disability in England. Medical treatment is imperative for the management of stroke and the risk reduction of recurrent stroke. The success of a medical treatment is determined largely by adherence. However, research has shown that adherence to medication in patients who have had a stroke is often suboptimal. Self-management interventions have been shown to improve adherence in long-term conditions. The impact of self-management interventions specifically on adherence to stroke medication is unknown. Objective: To review systematically the impact that self-management interventions have on adherence to stroke medication. Method: The online databases that were systematically searched included PsychINFO, MEDLINE, EMBASE, Scopus, Cochrane Database of Systematic Reviews, CINAHL and Web of Science. Reference lists of retrieved studies were handsearched. Results: Six studies met the criteria for inclusion in the systematic review. Self-management interventions for stroke patients were effective in improving adherence to stroke medication in the short term. However, in the longer term, these benefits were not maintained. Conclusions: Applying self-management interventions to improve medication adherence in stroke patients across integrated clinical settings shows promise. However, further development of such interventions and research is recommended, with more stringent methodologies and longer follow-up periods.
S troke is one of the leading causes of mortality and disability in the UK and can have a long-lasting and profound impact on a person's life (Chambers et al, 2011) .A stroke occurs when there is a blood clot or bleed in the brain. In England, approximately 110 000peoplehaveastrokeeachyear.Theeffectscanvary widely and can result in damage to physical, cognitive and emotional functioning (Department of Health (DH), 2007) . Some people may only be mildly affected, whereas others are severely affected (Brain Foundation, 2012) . Effects will Beatrice Chapman and Vanessa Bogle dependonthetypeofstrokeandtheareaofthebrainthat isdamaged(NationalStrokeAssociation(NSA),2012).There aretwomaintypesofstroke-ischaemicandhaemorrhagic. Ischaemicstrokesoccurwhenarteriescarryingbloodtoparts ofthebrainareblocked.Ahaemorrhagicstrokeoccurswhen abloodvesselruptures.Atransientischaemicattack(TIA)isa 'mini-stroke'andsimilartoanischaemicstroke,butsymptoms usuallypasswithin24hours.Thoseaffectedareatveryhigh risk of a recurrent stroke, which may result in more severe outcomes.Theoverallpossibilityofarecurrentstrokeforall typesofstrokeishigh,with30-43%ofpeoplelikelytohave onewithin5years (O'Carrolletal,2011) .
Stroke has been highlighted as a major challenge for the NHS,asemphasisedrecentlybynationalguidancesuchasthe NationalStrokeStrategy,andasanarearequiringimprovement (DH,2012) .Ithasbeenestimatedthatapproximately5%of totalNHScostsarespentontreatmentforstroke,amounting toapproximately£9billionayear (Sakaetal,2009) .Ageis amajorriskfactorforstrokeand,withanagingpopulation, the number of people at risk of stroke will continue to grow (Di Carlo, 2009) .Therefore designing and evaluating interventions for the primary and secondary prevention of stroke that can be used easily in clinical practice is key to reducing costs, preventing occurrence and recurrence, and managingtheconditionbetter.
Over the past few decades, medical and technological advances have transformed our understanding of and treatment of stroke, which has led to opportunities to save livesandreducedisability.Afterastrokehasoccurred,there are medical treatment options available that restore blood flowandenhancebrainfunctionwhenpartsofthebrainhave beendamaged (DH,2007) .Theseincludeanticoagulationand antiplatelettreatments (Alberts,2011) .Cholesterolandblood pressure medicines are also available. The Royal College of Physicians (2012) recommends that the management of patients after a stroke orTIA be the same. Research and clinical guidance therefore support the use of medicine to treat all types of stroke and to reduce the risk of recurrent stroke (DH,2007) .Theyshouldbestartedasearlyaspossible to reduce further damage and improve patient outcomes (Menardetal,2011) .
Adherence
Adherence to a medical regimen is defined as the extent to which a person's behaviour corresponds with agreed recommendations from a health professional (Lehane and McCarthy, 2009) . Medicine is the most frequent type of interventionusedbypatientswithhealthproblemsandlong-©2014MAHealthcareLtd term conditions, and is relied on heavily to improve health and manage illness (Picton andWright, 2012) .The success of a medical treatment is determined largely by adherence. But non-adherence to prescribed medication is widespread and perceived to be a significant problem (Horne, 2007; Chambersetal,2011) .
Non-adherence can be unintentional and intentional. Unintentionalnon-adherenceoccurswhensomeoneintends to take the medication but something prevents them from doing so (for example, forgetting or a physical disability). Intentional non-adherence occurs when someone actually decidesnottotakethemedication,ortakesitinawaythat isdifferentfromtherecommendedwayduetotheirbeliefs or illness perceptions (Horne, 2006; O'Carroll et al, 2011) . For example, someone may not like the side-effects of a medicationandintentionallynottakeit.
Thenegativeconsequencesofnon-adherencetomedication are considerable and can include poor health outcomes, increasedmorbidityandsubstantialcoststotheNHS (Horne, 2006) .Aroundhalfofpatientsfromdevelopedcountrieswho haveoneormorechronicconditionsdonotadheretotheir medication as recommended (Horne, 2006) . In the UK, it hasbeenestimatedthat£230millionworthofmedicinesare returnedtopharmacies.Thiscostdoesnottakeintoaccount thewastebypatientsthemselves (Horne,2006) .Thecostof wastagecoupledwithlossoftherapeuticbenefitisofahuge concern (DiMatteoetal,2002) . Despitetheevidencethatstrokemedicationisimperative for the management and prevention of recurrent stroke, adherence is frequently suboptimal (O'Carroll et al, 2011) . It has been reported that adherence to stroke medication maybelessthan50% (Irelandetal,2010) .Furthermore,half of patients starting antihypertensive medication following strokestoptakingitwithinoneyear (AdieandJames,2010) . Randomised controlled trials (RCTs) have shown that the risk of recurrent stroke is reduced by up to 38% when antiplateletagentsareadheredto (Fanetal,2010) .
Self-management interventions
The National Stroke Strategy (DH, 2007) has emphasised that money should be invested in helping people who have survived stroke to live independently through the provision of support in the community and in helping them manage their condition. Reviews have found that self-management interventions are effective in improving outcomesinpeoplewithlong-termconditions (Barlowetal, 2002) .Self-managementinterventionsaimtosupportpeople inmanagingtheirconditionbetter.Generally,theycomprise several components, including such things as provision of information, medication, problem-solving and support (Newmanetal,2004) .
Stroke patients perceive the educational information they receive as inadequate (Rodgers et al, 2001) . Inadequate educationcandamageadherencetopreventativestrategiesand psychosocialoutcomes (O'Mahoneyetal,1997) .Conversely, studieshaveshownthatcombinededucationalandcounselling interventions can improve adherence to medication; and interventions that include motivational interviewing, goalsettingandemotionalsupportdeliveredface-to-faceorover thephonehavebeeninfluentialinhelpingpeopleadhereto their medication (McManus et al, 2008; Ireland et al, 2010; Adie et al, 2010) .There is no literature specifically on the outcome of medication adherence in stroke, which is thus oneoftheobjectivesofthissystematicreview.
An important issue for self-management interventions is ensuringthatitseffectsaresustained.Maintaininglong-term benefits following an intervention is essential to changing behaviour. It has been found that several factors influence long-term maintenance of behaviour change, including the useofproblem-solvingandcopingskills (Newmanetal,2009) . Boostersessionsofaninterventionhavealsobeenshownto beeffectiveinmaintaininglong-termchange (Newmanetal, 2009) .Asystematicreviewfoundthatinterventionsthatwere deemedmorecomplex,inthattheyincludedacombination ofinformation,support,remindersandself-monitoring,were moreeffectiveinsustainingmedicationadherencethanmore basicinterventions,suchasinformation-givingalone (Haynes etal,1996) .
With the knowledge that there is a pressing need to improve stroke care due to an ageing population, coupled with the evidence that adherence to stroke medication is suboptimal, the aim of this systematic review is to assess the effectiveness of self-management interventions aimed at improving adherence to medication in stroke patients.The outcomeofadherencetomedicationwasspecificallyfocused onbecauseitisoneofthemajorfactorsinfluencingmortality and morbidity (DH, 2007) and is a major predictor of recurrentstroke (DH,2007) .Theobjectivesofthissystematic reviewwereto:
■ assesstheeffectivenessofself-managementinterventionson adherencetostrokemedication ■ assess the short-term (≤6 months) and long-term (≥6 months) impact of self-management interventions on adherencetostrokemedication.
Method

Inclusion criteria
Studiesthatwereeligiblewerethosethat:
■ Investigated people who had had a stroke but were not severelycognitivelyimpaired(i.e.theywereabletoremain independent)
■ Appliedpre-postandcontrolledtrialdesign(i.e.outcomes were measured before and after the intervention) with follow-upatleast3monthsaftertheintervention
Exclusion criteria
Studieswereexcludedthat:
■ Containedduplicatedata ■ Included patients who had been severely cognitively impairedbythestroke 
Types of study
Self-management intervention components
Only self-management intervention studies were included. Self-management interventions have been described as includingthreecomponents:information/education,problem solving/goalsettingandsupport (LorigandHolman,2003) . Thestudiesdidnotalwaysexplicitlystatethatinterventions were self-management interventions. However, if the intervention included all three components in some form, they were included-for example, a nurse-led intervention thatincludedinformationonstrokemedication,supportand strategiestocopewithside-effects.
Thestudiesincludedinterventionsthatweredeliveredfaceto-faceonaone-to-onebasisorinagroup,orbytelephone. Follow-uphadtobemeasuredatleast3monthspostbaseline toensureanadequatelengthoftimeforbehaviourchange. The interventions included were carried out by health or social-careprofessionals,orresearchers.
Outcome measures
The studies were included if the intervention measured adherencetostrokemedication.Mostofthestudiesmeasured other outcomes as well as medical adherence. As long as medicationadherencewasoneoftheoutcomes,thestudies were included. This systematic review focused only on medication adherence as an outcome, as it has been shown to be one of the biggest predictors of morbidity, mortality and recurrent stroke (DH, 2007) . The measures could be self-report,medicalmarkersandrecordedincidencesofnonadherence-for example, the medication compliance scale (Moriskyetal,2008) ,whichisaself-reportedscaletoassess unintentional and intentional medication non-adherence; blood pressure (Ellis et al, 2005) and recording measures (i.e.thenumberoftimesapatientdidnottaketheirstroke medication).
Search strategy to identify studies
Between February 2012 and July 2012, a systematic review of the literature was done on several online databases: PsychINFO, MEDLINE, EMBASE, Scopus, CINAHL and Web of Science.The search terms used were (stroke OR 'cerebrovascular accident' OR'cerebrovascular disease' OR 'transientischaemicattack'OR'TIA')AND(adherenceOR 'non-adherence'ORcomplianceOR'non-compliance'OR concordance)AND(intervention*ORtrialORprogramme ORprogram).Thesearchwaslimitedtoadults(>18years-old)andjournalarticlespublishedinthepreceding10years. Figure 1showstheresultsofthedatabasesearch .Inaddition, referencelistsofretrievedstudieswerehand-searched,aswere theCochraneDatabaseofSystematicReviewsandDatabase ofAbstractsofReviewsofEffectiveness(DARE).
The search began by looking for self-management intervention studies that incorporated stroke medication adherence as an outcome measure. Eligible studies were obtained by reading abstracts. Where the search only generated a small number of studies, an age limitation was notrequired.However,ifthesearchgeneratedalargenumber ofstudies(asEMBASEdid,forexample),theagelimitation was added. It was apparent from many of the abstracts that studieswereevaluatingtheclinicalefficacyofadrugrather than a behaviour change intervention.These studies were thereforeexcluded.
The studies that were deemed appropriate were then screenedfortypeofintervention.Initially,onlyRCTswere goingtobeincluded,butjustfourstudieswerefound.Sothe studytypewasexpandedtoincludequasi-experimentaltrials, resultinginthefindingoftwomorestudies.Hence,preand post(beforeandafter)measureswerearequirement,aswasa controlgroup.Theserequirementsruledoutfurtherstudies. Studies were excluded if they did not include a measure ofmedicationadherence.Someofthestudiesonlyincluded measuresforlifestyleadherence-i.e.adherencetoanexercise ordietregimen.Asthissystematicreviewwasconcernedwith assessing the effectiveness of self-management interventions onadherencetostrokemedication,theseeightstudieswere excluded. The studies were then screened to ensure they included self-management interventions. None of these studieswereexcluded.
Thestudieswerethenscreenedforparticipanttype:adults whowerenotcognitivelyimpaired.Allstudiesdescribedthe typeofstroketheparticipanthadhad,andlimitationswere inplacesothatonlyparticipantswhowereindependentor had not been severely cognitively impaired were included. Nostudieswereexcluded.Fromthisprocess,fivestudieswere identified. One of these studies was a long-term follow-up RCT of a study that was already included. It was decided that this study should be included, as it was important to evaluatethelong-termimpactoftheinterventionandithad beenpublishedasaseparatepaper.Ahandsearchofabstracts wasalsodoneforanymorerelevantpapers;twomorestudies were found. One of these was missing the results and the authorwascontacted.However,thefindingshadnotyetbeen published (Chengetal,2011 
Overview of interventions
AdieandJames's(2010)interventionwasdeliveredoverthe telephone by a researcher. It included brief motivational interviewing, counselling, goal setting and educational materialthatwastailoredtothepatients'needs. Claiborne's (2006) intervention was delivered face-to-face by a social worker initially and subsequently via telephone. Problem solving-medication issues, education and enhancement of self-care and counselling-was included. Ellis et al (2005) and McManus et al (2009) were nurse-led studies and includedface-to-facevisits.Thepatientsreceivedindividual advice and counselling about medication adherence, and all verbalinformationwasbackedupwithwritteneducational information. Extra time was available for question-andanswer problem solving. Hohmann et al (2009) reported on a pharmacist-led intervention, delivered face-to-face. It includedmedicationreview,acounsellinginterviewfocusing onspecificactionstobetaken,side-effects,anddetectingand solving stroke-drug-related problems. Lastly, Sit et al (2005) was led by nurses and delivered face-to-face.The sessions includedteaching,experiencesharing,individualgoalsetting andactionplanning,games,andreflection.
Results
Six studies met the inclusion criteria for this systematic review. Four were RCTs and two were quasi-experimental design studies.The quality rating of the studies was scored between 1 and 5; all the studies included in the systematic review were scored above three. A meta-analysis was not done as the studies used different measures of medication adherence. Similarities between the studies, as well as their differences,werealsoanalysedandarepresentedinTable 1.
Most of the studies analysed the data with t-tests or ANOVA/ANCOVA, and chi-squared tests, and stated the version of SPSS that had been used. There was enough informationtoreporteffectsizesinmostofthestudies.
Ofthesixstudies,threereportedthattheinterventionhad an effect on adherence to stroke medication.This was true ofClaiborne(2006),inwhichtheinterventionwasledbya social worker (p<0.05). Hohmann et al (2009) , by contrast, foundnoimpactonmedicationadherenceofthepharmacyled intervention (no p value reported). Ellis et al (2005) reported that the stroke nurse specialist (SNS) intervention loweredbloodpressureandreportedsignificanceat5months (p<0.05; CI -13.1 to -2.6). In Sit et al (2007) , the nurseled intervention also had a significant effect on medication adherence (p<0.001). McManus et al (2009) , who carried out a long-term follow-up of SNS intervention, found no statistical significance (p>0.05). Last,Adie and James (2010) foundnosignificanteffectofthetelephoneinterventionon medicationadherence(p>0.05).However,theydidreportan increaseinmedicationknowledge.
Most of the studies described the sample in detail, includingdescriptivevariablessuchasage,gender,ethnicity and socio-economic variables. There was a total of 789 participantsintheincludedstudies,withanaverageageof 67years;57%weremaleand43%female(determinedfrom theavailabledata).Sitetal(2007)hadasamplethathada high level of education, so generalisability may be limited. All the studies described the type and severity of stroke. Althoughdifferentmeasureswereusedtoassessseverityof strokedamage,itwasclearacrossthestudiesthatparticipants were only included if they were not severely cognitively damaged. For example,'patients with impairment (defined asanAbbreviatedMentalTest(AMT)score<5onscreening) were excluded from involvement' (Ellis et al, 2005) .The studies also stated when the participants had had the Gender: chi-square analysis showed there were significantly more women in the intervention group (7 men, 9 women) than in the control group (10, 2) Ethnicity: in both groups, the sample was predominantly white Drop-out rate was high (n=44) Mean age of the intervention group was 62.8; of the control group, 64
Gender: 55% of the intervention group was male; of the control group, 50%
Socioeconomic variables: the majority of participants were married (70.9%); the majority also had a high educational level with most achieving at least secondary-school-level education; most were retired and lived with family Level of stroke was minor and participants were medically stable, cognitively intact and independent in activities of daily living *N=total number of participants, I=intervention group, C=control group. Quality assessment was scored on a scale of 1 to 5 (low to high quality) Involved individual advice on lifestyle and medication compliance. All information was discussed and then written for patients; targets were decided (self-care planning); education and counselling were also included Intervention delivered by SNS Control group had care as usual, generic advice in outpatient clinic only, and GP appointments If a risk factor was found (for non-adherence) then patient advised to contact GP for 30-minute appointment (GPs were aware of study)
Started at discharge and involved monthly reviews by a SNS for 3 months/once a month in hospital Baseline pre-study (week 1) and follow-up was at 5 months Medical markers: blood pressure
Intervention was effective in lowering systolic blood pressure 4.07
As above
Baseline pre-study (week 1) and follow-up was 3.6 years Mixed: checked medication for out-of-date tablets
Patients asked if they considered themselves to be taking medication regularly
Inconsistent medicine checked
Effect size: 0.19
The intervention did not have any long-term benefit on medication adherence
3.56
Led by community-based pharmacies. Intervention involved counselling/ discussion of side-effects and medication, and goal setting with a local pharmacist in the community. Participants had one hospital session with a clinical pharmacist and then further sessions in the community with a pharmacist
Patients were assigned to at least one session of the intervention every 3 months. The length of the intervention was not stated. The control patient had standard care, not individualised support. Standard care included advice from a pharmacist, but did not include counselling Baseline measured at the stroke unit at week 1; follow-up was at 12 months Conducted in the community and led by nurses. It included individual goal setting and action plans, problem sharing and discussion of experiences in a group setting. This was incorporated into written action plans, which were reviewed in sessions. Each group had 10-12 participants Included eight weekly 2-hour sessions with a focus on goal setting and action plans or control (only medicine)
Baseline was measured at week 1 with follow-up at 3 months stroke-for example, within the preceding 3 months. All the interventions were started soon after the stroke had occurred, which was positive, since guidance suggests interveningassoonaspossible (Menardetal,2011) . The sample sizes across the studies differed largely. Some studies, such as Claiborne (2006) , had a very small sample size of 28 participants, whereas other studies had much largersamplesizes,suchasHohmannetal(2009)with255. Withdrawalsanddrop-outsinmostofthestudieswerealso discussed in detail. Drop-out rates were overall fairly mixed in relation to sample sizes. They ranged from zero (0%) (Claiborne, 2006; Adie and James, 2010) to 23% (Sit et al, 2005) .Drop-outrateswerealimitationforsomeofthestudies. The longer-term studies (>6 months) had higher drop-out rates and larger sample sizes. Given the nature of stroke, during the long-term follow-up period, some participants' conditionshaddeterioratedandsomeparticipantshaddied.
The method of randomisation was clearly stated.All the studies that were RCTs-four of the six-stated how they hadbeenrandomisedand,inthemain,itwascomputerised. In accordance with the inclusion criteria for this review, the remaining studies had quasi-experimental design and included pre and post (before and after) measures and a control and intervention group.These two studies assigned participantstoacontrolgroupintheformof'standardcare' ortoaninterventiongroup,whichwasclearlyexplained.
The designs of the self-management interventions were of good quality.The main components of the interventions wereconsistent.Forexample,theyallincludedadviceabout stroke,self-careplanning,goalsetting,personalisedfeedback, education and support. In the interventions, participants could discuss medication issues they were having and then put strategies in place to overcome them. Although the componentsweredescribed,theywerenotdescribedindetail.
Allbutoneoftheinterventionsincludedface-to-facevisits. Theremaininginterventionwasdeliveredoverthetelephone (AdieandJames,2010) .Thisstudydidnothaveaneffecton medication adherence. One study (Claiborne, 2006) began with a face-to-face visit, but then subsequent sessions were deliveredoverthetelephone,whichdidimprovemedication adherence. Including at least one initial face-to-face visit maybebeneficial,butfurtherresearchisneededbeforefirm conclusionscanbedrawn.
Therewasvariationinthefrequencyoftheinterventions. Onewasdonemonthlyviaface-to-faceinteractionorvia telephone (Ellisetal,2005; McManusetal,2008; thelatter wasthelong-termfollow-upofEllisetal) .Another (Adie et al, 2010) was sporadic, whereby an initial telephone conversation was followed by conversations at 1 month, 2 months and 4 months. Other interventions were weekly (Claiborne,2006; Sitetal,2005) .Somewerelessfrequent, such as every 3 months (Hohmann et al, 2009 ).The two thatwerethemostfrequent,weekly,hadasignificanteffect onmedicationadherence (Claiborne,2006; Sitetal,2005) . Thesesamestudiesalsoinvolvedmoretime-sessionslasted 1or2hours-whereassomeofthestudiesthathadpoorer outcomes involved 20-minute sessions (Adie et al, 2010) . The third study that had a significant finding involved a single intervention, which lasted 5 months, so although it waslessfrequent,itwaslongerinduration,whichmayhave been advantageous. Overall, those that were less frequent werealsolesseffective.
Thetimespaninwhichbaselinetofollow-upwasmeasured differed.Someinterventionsmeasuredfollow-upat3months post intervention (Sit et al, 2005; Claiborne, 2006) . One measured follow-up at 5 months (Ellis et al, 2005) . The remaining studies measured longer-term follow-up-i.e. post6months (McManusetal,2008; Hohmannetal,2009; AdieandJames,2010) .Thestudiesthatmeasuredfollow-up intheshorterterm,i.e.3to5months,hadbetteroutcomes comparedwiththosethatmeasuredfollow-upinthelonger term,indicatingtheeffectswerelostovertime.
The studies' measurement of medication adherence differed. Some used biological markers such as blood pressure, whereas others used self-report measures such as the Medical Compliance Questionnaire (Morisky et al, 2008) ,whichisawidelyusedscalethatidentifieswhether or not people take their medication. Others measured the number of times people did not take their medication (Claiborne, 2006) . There are limitations with all the differentmeasuresthatwereused.Forexample,self-report measures may be unreliable because of patient recall and bias, and using blood pressure as a measure of adherence may be influenced by confounding factors such as weight loss or physical activity. Because different measures were used,ameta-analysiswasnotpossible.
Discussion
This systematic review assessed the effectiveness of selfmanagementinterventionsonmedicationadherenceinstroke patients,andtheirshort-termandlong-termimpact.Overall, half of the findings support self-management strategies becominganintegralpartofstrokemanagement,butbecause halfdonot,firmconclusionscannotbedrawn.
The studies in this review that had significant findings had regular and frequent interventions-this is one of the review's main findings. It is also in line with the literature thathasfoundthatincreasedexposuretoaninterventionis associated with improvements and increased likelihood of positiveeffects (Rubaketal,2005) .Futureself-management interventionsforstrokethattargetmedicationadherenceare stronglyrecommendedtobestartedsoonafterthestrokeand deliveredfrequently(weeklyormonthly).
The impact that self-management interventions had on medication adherence in stroke patients was mixed, with half having an effect.All the studies included in this review incorporated education, problem solving, counselling and medication advice. Previous literature has found that a combinationoflifestylechangesandmedicinesmanagement is successful in improving patient outcomes (Powers et al, 2011) . Although the evidence from this review does not pointtoafirmconclusion,allthestudiesthatwereeffective includedallofthesecomponents,andhadfrequentandregular interventions. Therefore self-management interventions incorporatingacombinationofthesecomponents,aswellas beingdeliveredfrequently,showpromise. A further objective of this systematic review was to ascertain the impact of the interventions on short-term ©2014MAHealthcareLtd and long-term medication adherence in stroke. Overall, the interventions were effective in improving adherence in the shortterm,butnotinthelongterm.Thismayhavebeendue tothefrequencyoftheinterventions.Forexample,onestudy waseffectiveintheshortterm,but3yearslater,thepositive outcomeswerenotsustained.Implementingboostersessions maysustainthem:forexample,Newmanetal(2009)found thatself-managementinterventionsthathaveboostersessions are more effective in the long term than those that do not. Butfurtherresearchisneeded.
This systematic review found that, from the descriptions given, the studies at hand did not appear to be explicitly groundedintheory. AccordingtoHorne(2007) ,thereisalack of interventions that have been developed using theoretical models.Manyaredevelopedwithad-hocapproaches,making them insufficiently comprehensive. For example, there is evidencethatinterventionstargetingsocialsupportaremore effective (Di Matteo, 2004) . Although some of the studies may have incorporated strategies aimed at promoting social support,thestrategiesweremoreapartofthedesign,rather thanclearlydefined.Moreuse,andclearerdefinitionsof,the theoreticalmodelsarerecommended.
It is important to highlight some limitations of this systematicreview.Thestudiesinthisreviewwerecarriedout indifferentcountries,includingtheUK,Germany,USAand HongKong.Thegeneralisabilityofthefindingsthereforemay belimited.Someofthestudiesdidnothavesufficientsample sizes and some had high drop-out rates too. Future studies withadequatesamplesizesarehighlyrecommended.
Thissystematicreviewonlyexaminedmedicationadherence because this is one of the biggest influencers of recurrent strokeandpoormedicaloutcomes;withanagingpopulation, these issues will continue to grow (Fan et al, 2010) . In addition, interventions that improve medication adherence havebeenhighlightedasapriorityforpeoplewithlong-term conditionsandstrokeguidanceaccordswiththis (Hayneset al, 2008; O'Carroll et al, 2011) .As the interventions' main outcome measure was not always adherence, this may have affectedthefindings. A further limitation was that the studies used different measures of medication adherence.According to Fairman and Motheral (2000) , although there are a variety of methodsthatcanbeusedtomeasuremedicationadherence, there is no 'gold standard'. In all the literature searched, studies and systematic reviews measured adherence to medicationdifferently.
Practice implications
Previousliteraturehasfoundthatthereisalackofevidencebased interventions for prevention and management of stroke (Wei et al, 2010; Cheng et al, 2011) .There is no doubtthatfurtherresearchisneeded.Manyofthenegative health and social effects of stroke are preventable and treatable, and can be greatly reduced with appropriate medical interventions that are integrated into clinical practice (Sakaetal,2009) .Itwasinterestingtoseetherange ofhealthandsocial-caresettingstowhichself-management interventions incorporating medication adherence can be successfullyapplied.Itisimportantforfutureinterventions to be integrated into existing primary and secondary clinical practice; to be grounded in theory; to include severalcomponentsofself-management;andtobedelivered regularlyandfrequently-i.e.weeklyormonthly.Forlongterm benefits to be upheld, investigating the impact of boostersessionsisrecommended.Withanagingpopulation, the time is apt to start improving health outcomes and reducinghealthcarecosts.
Key POInTS
n Self-management interventions aimed at supporting adherence to stroke medication are invaluable n Integrating such interventions into existing clinical practice is effective and potentially cost-efficient n To be effective, self-management interventions for improving medical adherence in stroke patients need to be delivered regularly and frequently n Booster sessions are recommended to uphold long-term benefits n Further development is needed of interventions that are grounded in theory and have stringent methodologies
